CVS Health stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 67 to 78.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's proprietary rating identifies price action with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the best stocks tend to have an RS Rating of above 80 as they launch their largest climbs. See if CVS Health stock can continue to rebound and clear that threshold.
Is CVS Health Stock A Buy?
CVS Health stock is currently trading in a wide cup pattern. Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the medical stock manages to offer and clear a proper buy point.
Earnings grew 72% last quarter, up from -44% in the prior report. Revenue also increased, from 4% to 7%.
CVS Health stock holds the No. 2 rank among its peers in the Medical-Managed Care industry group. CVS Health is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
